BENEFITS
Hospital admissions are reduced and the patient?s quality of life is improved.
Improves the deformability of red blood cells in sickle cell anemia with some beneficial effects in reducing the frequency of vaso-occlusive crises
White blood cells reduction results in decrease of inflammatory mediators which causes a general improvement in the patient?s well-being devoid of debilitation pain.
Ensures compliance and therapeutic success
Ensures that patients will not discontinue their medication.
Availability is ensured throughout the year.